Door-to-needle time and the proportion of patients receiving intravenous thrombolysis in acute ischemic stroke: uniform interpretation and reporting

MeSH terms

• Administration, Intravenous / methods
• Emergency Medicine / methods*
• Emergency Medicine / standards
• Female
• Humans
• Male
• Needles*
• Recombinant Proteins / therapeutic use
• Stroke / drug therapy*
• Thrombolytic Therapy / methods*
• Thrombolytic Therapy / standards
• Time Factors
• Time-to-Treatment*
• Tissue Plasminogen Activator / therapeutic use*
• Treatment Outcome